The Neoplastic Potential of Liver Tumors Induced by Mixed-Function Oxidase Inducers in the Mouse

Butler WH (1996). A review of the hepatic tumors related to mixed-function oxidase induction in the mouse. Toxicol. Pathol. 24: 484-492.

Chang EH , Furth ME , Scolnick EM , and Lowy DR (1982). Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature (London) 297: 479-483.

Clemmesen J. and Hjalgrim-Jensen S. (1980). Epidemiological studies of medically used drugs. Arch. Toxicol. Suppl. 3: 19-25.

Counts JL and Goodman JI (1994). Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotion. Mol. Carcinogen. 11: 185-188.

Evans JG , Collins MA , Lake BG , and Butler WH (1992). The histology and development of hepatic nodules and carcinoma in C3H/He and C57BL/6 mice following chronic phenobarbitone administration. Toxicol. Pathol. 20: 585-594.

Farber E. and Rubin H. (1991). Cellular adaptation in the origin and development of cancer. Cancer Res. 51: 2751-2761.

Goldsworthy TL , Fransson-Steen R. , and Maranpot RR (1996). Importance of and approaches to quantification of hepatocyte apoptosis. Toxicol. Pathol . 24: 24-35.

Greaves P. (1996). The evaluation of potential human carcinogens: A histopathologist's point of view. Exp. Toxicol. Pathol. 48: 169-174.

Klaunig JE (1995). Role of oxidative stress in mouse hepatocarcinogenesis . In: Fifth Workshop on Mouse Liver Tumors, Summary Report . Mouse Liver Tumor Subcommittee, International Life Sciences Institute, Arlington, Virginia, pp. 13-14.

Loury DJ , Goldworthy TL , and Butterworth BE (1987). The value of measuring cell replication as a predictive index of tissue-specific tumorigenic potential. In: Neogenotoxic Mechanisms in Carcinogenesis, BE Butterworth and TJ Slaga (eds). 25 Banbury Report. Cold Spring Harbor Laboratory, New York, pp. 119-136.

McClain MR (1990). Mouse liver tumors and microsomal enzyme-inducing drugs: Experimental and clinical perspectives with phenobarbital. In: Mouse Liver Carcinogenesis: Mechanisms and Species Comparisons , Stevenson et al (eds). Alan R. Liss, New York, pp. 345-365.

Monro A. (1996). Are rodent carcinogenicity studies defensible for pharmaceutical agents? Exp. Toxicol. Pathol. 48: 155-166.

Newberne PM , Suphakarn V. , Punyarit P. , and de Carmago J. (1987). Nongenotoxic mouse liver carcinogens. In: Nongenotoxic Mechanisms in Carcinogenesis, BE Butterworth and TJ Slaga (eds). 25 Banbury Report. Cold Spring Harbor Laboratory , New York, pp. 165-178.

Olsen JH , Boice JD , Jensen JPA , and Fraumeni JF (1989). Cancer among epileptic patients exposed to anticonvulsant drugs. J. Natl. Cancer Inst. 81: 803-808.

Ray JS , Harbison ML , McClain MR , and Goodman JI (1994). Alterations in the methylation status and raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors . Mol. Carcinogen. 9: 155-166.

Ruch RJ and Klaunig JE (1986). Effects of tumor promoters, genotoxic carcinogens and hepatocytotoxins on mouse hepatocyte intercellular communication. Cell Biol. Toxicol. 2: 469-483.

Williams GM and Whysner J. (1996). Epigenetic carcinogens: Evaluation and risk assessment. Exp. Toxicol. Pathol. 48: 189-195.